Advertisement
U.S. markets open in 8 hours 8 minutes
  • S&P Futures

    5,208.25
    -6.50 (-0.12%)
     
  • Dow Futures

    39,210.00
    -13.00 (-0.03%)
     
  • Nasdaq Futures

    18,181.00
    -50.50 (-0.28%)
     
  • Russell 2000 Futures

    2,047.50
    -2.30 (-0.11%)
     
  • Crude Oil

    82.58
    -0.14 (-0.17%)
     
  • Gold

    2,162.50
    -1.80 (-0.08%)
     
  • Silver

    25.30
    +0.03 (+0.12%)
     
  • EUR/USD

    1.0870
    -0.0007 (-0.07%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.33
    -0.08 (-0.56%)
     
  • dólar/libra

    1.2716
    -0.0013 (-0.10%)
     
  • USD/JPY

    150.1970
    +1.0990 (+0.74%)
     
  • Bitcoin USD

    65,160.35
    -3,092.55 (-4.53%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,722.55
    -4.87 (-0.06%)
     
  • Nikkei 225

    39,866.64
    +126.24 (+0.32%)
     

Johnson & Johnson to seek buyer for medical device maker unit -WSJ

Aug 28 (Reuters) - Johnson & Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.

The sale of Cordis could fetch between $1.5 billion and $2 billion, one of the people told the Journal, adding that the sales process for the business was still at an early stage.

(http://on.wsj.com/1AYRKBY)

When contacted, J&J declined to comment on the matter.

Bridgewater, New Jersey based Cordis manufactures treatments for vascular disease including stents and catheters. It has a workforce of about 5000 employees.

Earlier this year, J&J sold another of its units, Ortho-Clinical Diagnostics Inc to private-equity firm Carlyle Group for $4.15 billion.

Analysts had pointed out at that time that the move highlighted J&J's determination not to waste resources on unloved divisions.

Other eminent deal talks in the medical device sector in recent times include Medtronic Inc's $43 billion bid for Covidien Plc, while Zimmer Holding Inc agreed to acquire Biomet Inc for about $13 billion.

(Reporting By Amrutha Penumudi in Bangalore; Editing by David Gregorio)

Advertisement